If one of these causes started around the same time you started taking a GLP-1, it could explain the changes youre experiencing
Moreover, we found that the expression of GLP-1 signaling-related genes ITPR1 and ADCY5 were significantly reduced in CRC tissues, and GLP-1 receptor agonist semaglutide impaired the migration capacity of CRC cells, indicating its protective role
This helps the body make use of glucose, preventing high blood sugarone of the most damaging effects of diabetes
In comparative receptor pharmacology, semaglutide is a GLP-1 receptor monoagonist, tirzepatide is a dual GLP-1/GIP agonist, and GLP-3 (RT) adds a third receptor target: the glucagon receptor
That doesnt mean GLP-1s are off-limits
however, its effects on whole-body glucose metabolism in humans remain inconclusive